| PK-Sim↗ | 163 | C# | 32 | 104 |
| Suite↗ | 137 | Rich Text Format | 6 | 13 |
| Forum↗ | 69 | — | 2 | 10 |
| OSPSuite-R↗ | 54 | R | 61 | 285 |
| OSP-PBPK-Model-Library↗ | 43 | — | 37 | 44 |
| MoBi↗ | 41 | C# | 45 | 193 |
| Pregnancy-Models↗ | 11 | — | 1 | 6 |
| docs↗ | 10 | R | 29 | 139 |
| Database-for-observed-data↗ | 7 | R | 4 | 8 |
| OSPSuite.Core↗ | 6 | C# | 39 | 111 |
| Vancomycin-Model↗ | 5 | R | 1 | 2 |
| OSPSuite.SimModel↗ | 5 | C++ | 2 | 10 |
| OSPSuite.ReportingEngine↗ | 5 | R | 11 | 14 |
| OSPSuite.Plots↗ | 4 | R | 19 | 37 |
| OSPSuite.Documentation↗ | 4 | — | 1 | 0 |
| OSP-Qualification-Reports↗ | 4 | — | 17 | 12 |
| OSPSuite.ParameterIdentification↗ | 3 | R | 9 | 17 |
| rSharp↗ | 2 | C# | 2 | 2 |
| open-systems-pharmacology.github.io↗ | 2 | HTML | 8 | 26 |
| Workflows↗ | 2 | CSS | 34 | 64 |
| OSPSuite.RUtils↗ | 2 | R | 5 | 5 |
| OSPSuite.GlobalSensitivity↗ | 2 | R | 1 | 22 |
| Erythromycin-Carbamazepine-DDI↗ | 1 | — | 1 | 1 |
| Gene-Expression-Databases↗ | 1 | R | 2 | 41 |
| developer-docs↗ | 1 | Batchfile | 6 | 38 |
| InstallationValidator↗ | 1 | C# | 10 | 30 |
| Verapamil-Model↗ | 1 | R | 1 | 0 |
| Itraconazole-Model↗ | 1 | R | 1 | 3 |
| Levonorgestrel↗ | 1 | R | 1 | 16 |
| Sildenafil-Model↗ | 1 | R | 1 | 2 |
| CVODES↗ | 1 | C | 1 | 0 |
| Cimetidine-Model↗ | 1 | R | 1 | 0 |
| Metformin-Model↗ | 1 | R | 1 | 5 |
| Midazolam-Model↗ | 1 | R | 1 | 0 |
| OSPSuite.BMLM↗ | 1 | — | 3 | 0 |
| Montelukast-Model↗ | 1 | R | 1 | 3 |
| Fluconazole-Model↗ | 0 | R | 1 | 0 |
| Alfentanil-Model↗ | 0 | R | 1 | 0 |
| OSMOSES↗ | 0 | — | 1 | 0 |
| Ethinylestradiol-Model↗ | 0 | R | 1 | 1 |
| Erythromycin-Model↗ | 0 | R | 1 | 1 |
| Moxidectin-Model↗ | 0 | R | 1 | 8 |
| Moclobemide-Model↗ | 0 | R | 1 | 1 |
| OSPSuite.BuildingBlockTemplates↗ | 0 | — | 2 | 2 |
| Erythromycin-Alprazolam-DDI↗ | 0 | — | 2 | 1 |
| OSPSuite.Dimensions↗ | 0 | — | 2 | 8 |
| Dextromethorphan-Model↗ | 0 | — | 1 | 8 |
| Extended-Batch-Comparison↗ | 0 | — | 1 | 0 |
| Desipramine-Model↗ | 0 | — | 1 | 2 |
| Create-Qualification-Reports↗ | 0 | — | 3 | 18 |
| OSPSuite.QualificationPlanEditor↗ | 0 | R | 32 | 145 |
| Mexiletine-Model↗ | 0 | R | 1 | 2 |
| Mefenamic_acid-Dapagliflozin-DDI↗ | 0 | — | 1 | 0 |
| OSPSuite.ReportingFramework↗ | 0 | R | 11 | 24 |
| Mefenamic-acid-Model↗ | 0 | R | 1 | 1 |
| OSPSuite.SimModel.Solver.CVODES↗ | 0 | C++ | 1 | 4 |
| Omeprazole-Model↗ | 0 | R | 1 | 3 |
| Bedaquiline-Model↗ | 0 | R | 1 | 24 |
| Paracetamol-Model↗ | 0 | R | 1 | 43 |
| Pediatric_Qualification_Package_CYP3A4_Ontogeny↗ | 0 | R | 1 | 2 |
| Pediatric_Qualification_Package_P-gp_Ontogeny↗ | 0 | R | 1 | 1 |
| Bedaquilin-Model↗ | 0 | R | 1 | 24 |
| Probenecid-Furosemide-DDI↗ | 0 | R | 1 | 0 |
| Propofol-Model↗ | 0 | R | 1 | 2 |
| Qualification-DDI-CYP2C19↗ | 0 | R | 1 | 0 |
| Qualification-DDI-CYP3A4↗ | 0 | R | 3 | 4 |
| Qualification-DDI-P-gp↗ | 0 | R | 1 | 5 |
| Qualification-HI↗ | 0 | R | 1 | 2 |
| QualificationRunner↗ | 0 | C# | 7 | 27 |
| Raltegravir-Model↗ | 0 | R | 1 | 2 |
| Rifampicin-Midazolam-DDI↗ | 0 | — | 1 | 0 |
| Rifampicin-Model↗ | 0 | R | 1 | 1 |
| S-Mephenytoin-Model↗ | 0 | R | 1 | 2 |
| Lisinopril-model↗ | 0 | R | 1 | 2 |
| Sufentanil-Model↗ | 0 | R | 1 | 1 |
| Atorvastatin-Model↗ | 0 | R | 2 | 6 |
| Tizanidine-Model↗ | 0 | R | 1 | 0 |
| Triazolam-Model↗ | 0 | R | 1 | 1 |
| Amikacin-Model↗ | 0 | R | 1 | 1 |
| Verapamil-Digoxin-DDI↗ | 0 | — | 1 | 1 |
| Verapamil-Midazolam-DDI↗ | 0 | — | 1 | 0 |
| Itraconazole-Midazolam-DDI↗ | 0 | — | 1 | 0 |
| Warfarin-Model↗ | 0 | R | 1 | 8 |
| Isoniazid-Model↗ | 0 | R | 1 | 44 |
| Griseofulvin-Model↗ | 0 | R | 1 | 21 |
| Alprazolam-Model↗ | 0 | R | 1 | 1 |
| Felodipine-Model↗ | 0 | R | 1 | 0 |
| qualificationEditor↗ | 0 | R | 1 | 15 |
| Moxifloxacin-Model↗ | 0 | R | 1 | 34 |
